Cargando…

Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”

INTRODUCTION: Founded in 2019, the “ResISSSTE Cerebro” program is the first and only stroke network within the Mexican public health system. One advanced stroke center (ASC) and seven essential stroke centers (ESC) provide acute stroke (AS) care through a modified hub-and-spoke model. This study des...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifacio-Delgadillo, Dulce María, Castellanos-Pedroza, Enrique, Martínez-Guerra, Bernardo Alfonso, Sánchez-Martínez, Claudia Marisol, Marquez-Romero, Juan Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992879/
https://www.ncbi.nlm.nih.gov/pubmed/36908627
http://dx.doi.org/10.3389/fneur.2023.1103066
_version_ 1784902416889544704
author Bonifacio-Delgadillo, Dulce María
Castellanos-Pedroza, Enrique
Martínez-Guerra, Bernardo Alfonso
Sánchez-Martínez, Claudia Marisol
Marquez-Romero, Juan Manuel
author_facet Bonifacio-Delgadillo, Dulce María
Castellanos-Pedroza, Enrique
Martínez-Guerra, Bernardo Alfonso
Sánchez-Martínez, Claudia Marisol
Marquez-Romero, Juan Manuel
author_sort Bonifacio-Delgadillo, Dulce María
collection PubMed
description INTRODUCTION: Founded in 2019, the “ResISSSTE Cerebro” program is the first and only stroke network within the Mexican public health system. One advanced stroke center (ASC) and seven essential stroke centers (ESC) provide acute stroke (AS) care through a modified hub-and-spoke model. This study describes the workflow, metrics, and outcomes in AS obtained during the program's third year of operation. MATERIALS AND METHODS: Participants were adult beneficiaries of the ISSSTE health system in Mexico City with acute focal neurological deficit within 24 h of symptom onset. Initial evaluation could occur at any facility, but the stroke team at the ASC took all decisions regarding treatment and transfers of patients. Registered variables included demographics, stroke risk factors, AS treatment workflow time points, and clinical outcome measures. RESULTS: We analyzed data from 236 patients, 104 (44.3%) men with a median age of 71 years. Sixty percent of the patients were initially evaluated at the ESC, and 122 (85.9%) were transferred to the ASC. The median transfer time was 123 min. The most common risk factor was hypertension (73.6%). Stroke subtypes were ischemic (86.0%) and hemorrhagic (14.0%). Median times for onset-to-door, door-to-imaging, door-to-needle, and door-to-groin were: 135.5, 37.0, 76.0, and 151.5 min, respectively. The rate of intravenous thrombolysis was 35%. Large vessel occlusion was present in 63 patients, from whom 44% received endovascular therapy; 71.4% achieved early clinical improvement (median NIHSS reduction of 11 points). Treatment-associated morbimortality was 3.4%. CONCLUSION: With the implementation of a modified hub-and-spoke model, this study shows that delivery of AS care in low- and middle-income countries is feasible and achieves good clinical outcomes.
format Online
Article
Text
id pubmed-9992879
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99928792023-03-09 Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro” Bonifacio-Delgadillo, Dulce María Castellanos-Pedroza, Enrique Martínez-Guerra, Bernardo Alfonso Sánchez-Martínez, Claudia Marisol Marquez-Romero, Juan Manuel Front Neurol Neurology INTRODUCTION: Founded in 2019, the “ResISSSTE Cerebro” program is the first and only stroke network within the Mexican public health system. One advanced stroke center (ASC) and seven essential stroke centers (ESC) provide acute stroke (AS) care through a modified hub-and-spoke model. This study describes the workflow, metrics, and outcomes in AS obtained during the program's third year of operation. MATERIALS AND METHODS: Participants were adult beneficiaries of the ISSSTE health system in Mexico City with acute focal neurological deficit within 24 h of symptom onset. Initial evaluation could occur at any facility, but the stroke team at the ASC took all decisions regarding treatment and transfers of patients. Registered variables included demographics, stroke risk factors, AS treatment workflow time points, and clinical outcome measures. RESULTS: We analyzed data from 236 patients, 104 (44.3%) men with a median age of 71 years. Sixty percent of the patients were initially evaluated at the ESC, and 122 (85.9%) were transferred to the ASC. The median transfer time was 123 min. The most common risk factor was hypertension (73.6%). Stroke subtypes were ischemic (86.0%) and hemorrhagic (14.0%). Median times for onset-to-door, door-to-imaging, door-to-needle, and door-to-groin were: 135.5, 37.0, 76.0, and 151.5 min, respectively. The rate of intravenous thrombolysis was 35%. Large vessel occlusion was present in 63 patients, from whom 44% received endovascular therapy; 71.4% achieved early clinical improvement (median NIHSS reduction of 11 points). Treatment-associated morbimortality was 3.4%. CONCLUSION: With the implementation of a modified hub-and-spoke model, this study shows that delivery of AS care in low- and middle-income countries is feasible and achieves good clinical outcomes. Frontiers Media S.A. 2023-02-22 /pmc/articles/PMC9992879/ /pubmed/36908627 http://dx.doi.org/10.3389/fneur.2023.1103066 Text en Copyright © 2023 Bonifacio-Delgadillo, Castellanos-Pedroza, Martínez-Guerra, Sánchez-Martínez and Marquez-Romero. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Bonifacio-Delgadillo, Dulce María
Castellanos-Pedroza, Enrique
Martínez-Guerra, Bernardo Alfonso
Sánchez-Martínez, Claudia Marisol
Marquez-Romero, Juan Manuel
Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title_full Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title_fullStr Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title_full_unstemmed Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title_short Delivering acute stroke care in a middle-income country. The Mexican model: “ResISSSTE Cerebro”
title_sort delivering acute stroke care in a middle-income country. the mexican model: “resissste cerebro”
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992879/
https://www.ncbi.nlm.nih.gov/pubmed/36908627
http://dx.doi.org/10.3389/fneur.2023.1103066
work_keys_str_mv AT bonifaciodelgadillodulcemaria deliveringacutestrokecareinamiddleincomecountrythemexicanmodelresissstecerebro
AT castellanospedrozaenrique deliveringacutestrokecareinamiddleincomecountrythemexicanmodelresissstecerebro
AT martinezguerrabernardoalfonso deliveringacutestrokecareinamiddleincomecountrythemexicanmodelresissstecerebro
AT sanchezmartinezclaudiamarisol deliveringacutestrokecareinamiddleincomecountrythemexicanmodelresissstecerebro
AT marquezromerojuanmanuel deliveringacutestrokecareinamiddleincomecountrythemexicanmodelresissstecerebro